Open access journal for cardiovascular medicine Indexed in SCIE, PubMed, Scopus, DOAJ, and more. COPE-member IF: 2.2 📩:RCM@imrpress.com

Singapore
🫀 When calcium obscures the coronary arteries, can AI help reveal the truth? Heavy coronary calcification remains a major challenge in CCTA interpretation. A commentary explores how a novel deep learning model may improve the assessment of calcified coronary plaques and enhance diagnostic performance. #Cardiology #AI #MedicalImaging
1
4
249
📄 Read the full commentary: imrpress.com/journal/RCM/27/… ✍️ Author: Zhonghua Sun 🏛 Affiliations: Discipline of Medical Radiation Sciences, Curtin School of Diagnostic and Therapeutic Sciences, Curtin University, Curtin Medical Research Institute, Curtin University #Cardiology #ArtificialIntelligence #MedicalImaging
2
97
📢 We are pleased to share this new collaboration with the Monash Victorian Heart Institute. Looking forward to supporting cardiovascular research dissemination and international academic exchange with the global cardiovascular community.
📢 IMR Press is pleased to announce a new academic collaboration with the Monash Victorian Heart Institute @MonashVHI , supporting cardiovascular research dissemination, knowledge exchange, and international academic collaboration. #IMRPress #CardiovascularResearch #Research
6
366
🫀 Vaccination may be more than infection prevention — it could also be part of cardiovascular prevention. Respiratory infections can act as triggers for acute cardiovascular events through inflammation, thrombosis, and plaque destabilization. A review explores the emerging role of vaccines in reducing cardiovascular risk and highlights their place in modern prevention strategies. #Cardiology #CardiovascularPrevention #Vaccination
1
1
7
382
⚡ A new cardiac technology enters the real world. How do we track its safety? Pulsed field ablation (PFA) has rapidly expanded for atrial fibrillation treatment. This study used natural language processing (NLP) to analyze nearly 7,000 FDA post-market reports, exploring: 🔹 Adverse event patterns 🔹 Device malfunction profiles 🔹 Real-world safety surveillance
3
7
20
1,571
🫀 Clinical trials shape the future of medicine — but who is represented in them? A systematic review examined demographic representation in transthyretin-associated cardiac amyloidosis (ATTR-CM) clinical trials. 1️⃣ 16 completed US-based ATTR-CM trials were analyzed 2️⃣ Demographic reporting improved after the 2017 FDA Final Rule 3️⃣ Black participants remained underrepresented compared with disease prevalence Improving trial diversity is essential for generating evidence that reflects the patients affected. #Cardiology #Amyloidosis #ClinicalTrials
4
1
7
428
📄 Read the full article: imrpress.com/journal/RCM/27/… ✍️ Authors: Dimitri Ford @dimitrifordmd , Chima Amadi, Akshay Chandora, et al. 🏛 Affiliations: Department of Internal Medicine, Morehouse School of Medicine, Atlanta, GA, USA Division of Cardiology, Emory School of Medicine, Atlanta, GA, USA Division of Cardiology, Morehouse School of Medicine, Atlanta, GA, USA
1
91
🫀 The immune system may influence more than inflammation — it may also affect vascular health. Aortic aneurysms are traditionally linked to factors such as aging, hypertension, and genetics. This review explores how autoimmune-related inflammation and vascular remodeling may contribute to aneurysm development. #Cardiology #VascularMedicine #Immunology
2
2
18
596
🫀 Call for Papers | The next breakthrough in acute coronary syndromes (ACS) care may come from better risk stratification, smarter intervention, and personalized treatment. High-Risk Acute Coronary Syndromes: Diagnosis, Intervention, Pharmacology & Prognosis Topics include: 🔹 AI & biomarkers 🔹 PCI and imaging 🔹 Cardiogenic shock 🔹 Antithrombotic and lipid-lowering strategies Guest Editor: Dr. Josip A. Borovac 📅 Deadline: 30 Sep 2027 #Cardiology #ACS
2
2
14
675
🫀 In older patients with atrial fibrillation, one size does not fit all. Dr. Francis Jonathan Ha discusses the evolving landscape of AF procedures, including: 1️⃣ Pulsed field ablation 2️⃣ Conduction system pacing 3️⃣ Leadless pacing 4️⃣ Left atrial appendage closure A conversation on balancing innovation, evidence, and individualized decision-making. 🎥 Watch the interview 👇 #Cardiology #AtrialFibrillation #Electrophysiology
1
1
6
500
🫀 How do dying heart cells shape myocardial injury? Myocardial ischemia/reperfusion injury involves complex cell death pathways. A review explores the potential interplay between: 1️⃣ Ferroptosis — iron-dependent oxidative cell death 2️⃣ Pyroptosis — inflammatory cell death 3️⃣ Their molecular connections in cardiac injury Understanding these pathways may reveal new therapeutic opportunities for protecting the heart. #Cardiology #Cardioprotection #CellDeath
1
5
16
587
🫀 Beyond the limbs: could lipedema affect the cardiovascular system? Lipedema is frequently underdiagnosed and often confused with obesity or lymphedema. This review examines current evidence on potential myocardial, valvular, and vascular abnormalities associated with lipedema. #Cardiology #WomenHealth #CardiovascularResearch
2
3
15
2,532
🫀 Welcome, Prof. Oscar Campuzano, MD, PhD, to the Editorial Board of Reviews in Cardiovascular Medicine! Affiliated with the University of Girona, Spain, Dr. Campuzano’s research focuses on: 🔹 Cardiovascular genetics 🔹 Inherited arrhythmias 🔹 Molecular autopsy We look forward to his insights and contributions to the cardiovascular research community. #Cardiology #Genetics #Arrhythmia
1
10
580
🫀 Lp(a): the next frontier in cardiovascular prevention A genetically determined cardiovascular risk factor, emerging targeted therapies, and one key question: Will lowering Lp(a) translate into fewer cardiovascular events? #Cardiology #Lipidology #CardiovascularRisk
1
10
36
5,647
Sharing insights from Prof. Gianni D. Angelini, Emeritus Professor of Cardiac Surgery at the University of Bristol and British Heart Foundation Professor of Cardiac Surgery. 🫀 Reflecting on more than 40 years in cardiac surgery, this conversation goes beyond techniques and innovations, offering insights into the experiences, challenges, and human side behind a lifelong dedication to improving patient care.
🫀 AI will not replace cardiac surgeons—but it may change how they make decisions. Prof. Gianni D. Angelini reflects on four decades of cardiac surgery, from coronary revascularization and off-pump CABG to the evolving role of AI in risk prediction and surgical practice.
1
7
484